Search
for
Sort by
Research 31–60 of 1000+
- Faculty Opinions recommendation of Hair follicle stem cell-specific PPARgamma deletion causes scarring alopecia.
- Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications
- Early skin seeding regulatory T cells modulate PPARγ-dependent skin pigmentation
- Maternal PPARγ protects nursing neonates by suppressing the production of inflammatory milk
- 1380 PPAR-γ modulation as a novel therapeutic strategy for scarring alopecia
- Androgens modify Wnt agonists/antagonists expression balance in dermal papilla cells preventing hair follicle stem cell differentiation in androgenetic alopecia
- Lichen planopilaris treated by the peroxisome proliferator activated receptor-γ agonist pioglitazone: Lack of lasting improvement or cure in the majority of patients
- A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
- Epidermal PPARγ Is a Key Homeostatic Regulator of Cutaneous Inflammation and Barrier Function in Mouse Skin
- A comparative study of a gonadotropin-releasing hormone agonist and finasteride on idiopathic hirsutism.
- The Role of PPARβ/δ-Related Lipid Metabolism in High-Altitude Adaptation of Yak Coat Based on Proteomics and Metabolomics
- Hormone therapy in acne
- New Treatments for Hair Loss
- Postmenopausal Ovarian Hyperthecosis Associated with Rapid Testosterone Excess
- LB1081 Three-dimensional imaging of tight junction-network across multiple layers of human epidermis by array tomography using backscattered electron-mode scanning electron microscopy
- The role of nuclear hormone receptors in cutaneous wound repair
- How to diagnose a lipodystrophy syndrome
- Photo-downregulation of SIRT4 mitigates aging in mice by enhancing H3K9ac via fatty acid metabolism
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- An update of the pathogenesis of frontal fibrosing alopecia: What does the current evidence tell us?
- Enhanced Insights into Frontal Fibrosing Alopecia: Advancements in Pathogenesis Understanding and Management Strategies
- In vitro hair growth-promoting effects of araliadiol via the p38/PPAR-γ signaling pathway in human hair follicle stem cells and dermal papilla cells
- Lichen Planopilaris
- 1377 Decoding frontal fibrosing alopecia and lichen planopilaris: Macrophages hold the key?
- 1379 Cell of origin contributes to the melanoma diversity
- Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
- Expression of Peroxisome Proliferator Activated Receptors (PPARs) in Human Hair Follicles and PPARα Involvement in Hair Growth
- Polycystic Ovary Syndrome and Its Differential Diagnosis
- Resveratrol derivatives: a patent review (2009 – 2012)
- Androgen receptor modulators: a review of recent patents and reports (2012-2018)